Bellevue Life Sciences Acquisition Corp. (BLAC)

NASDAQ: BLAC · IEX Real-Time Price · USD
10.58
-0.06 (-0.56%)
Mar 1, 2024, 4:00 PM EST - Market closed
Market Cap 95.80M
Revenue (ttm) n/a
Net Income (ttm) 75,043
Shares Out 9.06M
EPS (ttm) 0.01
PE Ratio 1,058.00
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 240
Open 10.58
Previous Close 10.64
Day's Range 10.58 - 10.61
52-Week Range 10.09 - 11.16
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About BLAC

Bellevue Life Sciences Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company intends to acquire companies in the healthcare industry. Bellevue Life Sciences Acquisition Corp. was founded in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC. [Read more]

Industry Shell Companies
Sector Financials
IPO Date Feb 10, 2023
Country United States
Stock Exchange NASDAQ
Ticker Symbol BLAC
Full Company Profile

Financial Performance

Financial Statements

News

OSR Holdings Co., Ltd. Enters Into Business Combination Agreement with Bellevue Life Sciences Acquisition Corp.

BELLEVUE, Wash. and SEOUL, South Korea , Nov. 16, 2023 /PRNewswire/ -- Bellevue Life Sciences Acquisition Corp. (Nasdaq: BLAC), a publicly traded special purpose acquisition company ("BLAC"), and OSR ...

3 months ago - PRNewsWire

Bellevue Life Sciences Acquisition Corp. and OSR Holdings Sign an Exclusive Letter of Intent for a Business Combination

BELLEVUE, Wash. and SEOUL, South Korea, July 11, 2023 /PRNewswire/ -- Bellevue Life Sciences Acquisition Corp. (Nasdaq: BLAC), a publicly traded special purpose acquisition company ("BLAC"), and OSR H...

8 months ago - PRNewsWire

Bellevue Life Sciences Acquisition Corp. Announces Closing of Full Over-allotment Option

BELLEVUE, Wash. , Feb. 21, 2023 /PRNewswire/ -- Bellevue Life Sciences Acquisition Corp. (the "Company" or "we") today announced the closing of the over-allotment option that the Company granted to th...

1 year ago - PRNewsWire